283 related articles for article (PubMed ID: 26867887)
1. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
Pötter R; Federico M; Sturdza A; Fotina I; Hegazy N; Schmid M; Kirisits C; Nesvacil N
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):588-97. PubMed ID: 26867887
[TBL] [Abstract][Full Text] [Related]
2. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer.
Smet S; Nesvacil N; Knoth J; Sturdza A; Najjari-Jamal D; Jelinek F; Kronreif G; Pötter R; Widder J; Kirisits C; Schmid MP
Strahlenther Onkol; 2020 Nov; 196(11):983-992. PubMed ID: 32621011
[TBL] [Abstract][Full Text] [Related]
3. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
[TBL] [Abstract][Full Text] [Related]
5. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
6. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
Swanick CW; Castle KO; Vedam S; Munsell MF; Turner LM; Rauch GM; Jhingran A; Eifel PJ; Klopp AH
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):793-800. PubMed ID: 27788952
[TBL] [Abstract][Full Text] [Related]
8. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
[TBL] [Abstract][Full Text] [Related]
9. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours.
Viswanathan AN; Dimopoulos J; Kirisits C; Berger D; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):491-8. PubMed ID: 17331668
[TBL] [Abstract][Full Text] [Related]
12. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
[TBL] [Abstract][Full Text] [Related]
13. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
[TBL] [Abstract][Full Text] [Related]
14. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.
Viswanathan AN; Erickson B; Gaffney DK; Beriwal S; Bhatia SK; Lee Burnett O; D'Souza DP; Patil N; Haddock MG; Jhingran A; Jones EL; Kunos CA; Lee LJ; Lin LL; Mayr NA; Petersen I; Petric P; Portelance L; Small W; Strauss JB; Townamchai K; Wolfson AH; Yashar CM; Bosch W
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):320-8. PubMed ID: 25304792
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
[TBL] [Abstract][Full Text] [Related]
16. Comparison of measurements of the uterus and cervix obtained by magnetic resonance and transabdominal ultrasound imaging to identify the brachytherapy target in patients with cervix cancer.
van Dyk S; Kondalsamy-Chennakesavan S; Schneider M; Bernshaw D; Narayan K
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):860-5. PubMed ID: 24462382
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
18. Comparison of CTV
Mendez LC; Ravi A; Martell K; Raziee H; Alayed Y; Wronski M; Paudel M; Barnes E; Taggar A; Wong CS; Leung E
Radiat Oncol; 2020 Apr; 15(1):73. PubMed ID: 32252792
[TBL] [Abstract][Full Text] [Related]
19. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination.
Hegazy N; Pötter R; Kirisits C; Berger D; Federico M; Sturdza A; Nesvacil N
Acta Oncol; 2013 Oct; 52(7):1345-52. PubMed ID: 23905674
[TBL] [Abstract][Full Text] [Related]
20. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]